India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
Seema Agrawal, a senior Indian Police Service (IPS) officer, has been appointed as the new…
Tamil Nadu has achieved the highest real economic growth rate in India for the year…
Samata Diwas is celebrated every year on April 5 to remember the birth anniversary of…
On April 5, 2025, Prime Minister Narendra Modi was awarded Sri Lanka’s highest civilian honour,…
On April 4, 2025, Bangladesh officially became the new Chair of BIMSTEC for the next…
HIL Ltd, a major player in the building materials industry and part of the USD…